Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

37.35p
   
  • Change Today:
    -0.13p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 361,992
  • Market Cap: £112.59m
  • RiskGrade: 479

Latest ShareCast News

Futura has 'transformational year' in 2023

By Iain Gilbert

Date: Tuesday 06 Feb 2024

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Futura Medical extends agreement with Cooper Consumer Health

By Josh White

Date: Monday 15 Jan 2024

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Futura Medical wins European patent for erectile dysfunction gel

By Josh White

Date: Monday 02 Oct 2023

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Futura Medical shares rise on ED licensing deal ... 17-Jul-2023 ShareCast
Futura's erection gel launched over-the-counter ... 18-Apr-2023 ShareCast
Futura gearing up for US approval, launches of e... 13-Dec-2022 ShareCast
Futura Medical completes FDA work for erectile t... 03-Oct-2022 ShareCast
Futura signs up Korean partner for erection gel ... 23-Mar-2022 ShareCast
Futura Medical makes good progress with topical ... 20-Dec-2021 ShareCast
Futura Medical inks licensing deal with Labtec P... 27-Sep-2021 ShareCast
Futura enters erection gel licensing deal with M8 31-Aug-2021 ShareCast
Futura Medical makes progress with topical erect... 28-Jun-2021 ShareCast
Thursday broker round-up 03-Jun-2021 ShareCast
Futura Medical surges on EU approval for topical... 30-Apr-2021 ShareCast
Futura Medical gets FDA OK for confirmatory stud... 22-Mar-2021 ShareCast
Futura's topical erection gel recommended for EU... 19-Mar-2021 ShareCast
Futura makes solid progress on approval for erec... 08-Dec-2020 ShareCast
Futura Medical narrows losses as it progresses e... 16-Sep-2020 ShareCast
Futura Medical upbeat on cannabidiol gel lab work 04-Aug-2020 ShareCast
Futura makes good progress with topical erectile... 24-Jun-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 37.35p
Change Today -0.13p
% Change -0.33 %
52 Week High 65.00
52 Week Low 25.50
Volume 361,992
Shares Issued 301.45m
Market Cap £112.59m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.91% below the market average48.91% below the market average48.91% below the market average48.91% below the market average48.91% below the market average
21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average
Price Trend
42.54% above the market average42.54% above the market average42.54% above the market average42.54% above the market average42.54% above the market average
85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:26 1,577 @ 37.46p
15:10 100,000 @ 38.48p
15:15 1,000 @ 37.65p
15:11 7,609 @ 37.65p
15:11 16,168 @ 37.65p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page